2-169297016-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004525.3(LRP2):​c.428-2306G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.621 in 151,950 control chromosomes in the GnomAD database, including 30,711 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.62 ( 30711 hom., cov: 31)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0980

Publications

5 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.428-2306G>A intron_variant Intron 4 of 78 ENST00000649046.1 NP_004516.2
LRP2XM_011511183.4 linkc.428-2306G>A intron_variant Intron 4 of 77 XP_011509485.1
LRP2XM_047444340.1 linkc.-497-2306G>A intron_variant Intron 4 of 78 XP_047300296.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.428-2306G>A intron_variant Intron 4 of 78 NM_004525.3 ENSP00000496870.1
LRP2ENST00000443831.1 linkc.428-2306G>A intron_variant Intron 4 of 22 2 ENSP00000409813.1

Frequencies

GnomAD3 genomes
AF:
0.621
AC:
94296
AN:
151830
Hom.:
30714
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.425
Gnomad AMI
AF:
0.656
Gnomad AMR
AF:
0.513
Gnomad ASJ
AF:
0.751
Gnomad EAS
AF:
0.560
Gnomad SAS
AF:
0.725
Gnomad FIN
AF:
0.739
Gnomad MID
AF:
0.764
Gnomad NFE
AF:
0.735
Gnomad OTH
AF:
0.635
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.621
AC:
94323
AN:
151950
Hom.:
30711
Cov.:
31
AF XY:
0.621
AC XY:
46123
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.425
AC:
17589
AN:
41422
American (AMR)
AF:
0.512
AC:
7808
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.751
AC:
2605
AN:
3470
East Asian (EAS)
AF:
0.560
AC:
2880
AN:
5144
South Asian (SAS)
AF:
0.723
AC:
3487
AN:
4820
European-Finnish (FIN)
AF:
0.739
AC:
7808
AN:
10566
Middle Eastern (MID)
AF:
0.764
AC:
223
AN:
292
European-Non Finnish (NFE)
AF:
0.735
AC:
49985
AN:
67972
Other (OTH)
AF:
0.637
AC:
1341
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1707
3414
5120
6827
8534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.689
Hom.:
121793
Bravo
AF:
0.590
Asia WGS
AF:
0.611
AC:
2126
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
8.1
DANN
Benign
0.50
PhyloP100
0.098
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2673164; hg19: chr2-170153526; API